Archives for October 24, 2007

← 2007

BioSPM drives JPK into 'Technology Fast 50'

By  Dr Matt Wilkinson

Scanning probe microscope (SPM) maker, JPK Instruments has been named as Germany's fastest growing nanotechnology company in accounting firm Deloitte's 'Technology Fast 50'.

GSK cut down by Avandia scare

By  Anna Lewcock

GlaxoSmithKline (GSK) has emerged as the latest pharma firm to announce closures and job cuts along with its third quarter results, yet another casualty of generic competition and product safety scares.

Sanofi slammed by FDA over failure to act on Ketek fraud

By  Kirsty Barnes

The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm continues to deny.

Wockhardt makes latest US move

By  staff reporter

Indian generics specialist Wockhardt is continuing its drive to strengthen its foothold in the US market, snapping up US firm Morton Grove Pharmaceuticals.

Sigma-Aldrich set to break $2bn yearly sales barrier

By  Dr Matt Wilkinson

Sigma-Aldrich continued its strong year with both revenues and pre-tax profits showing strong double-digit growth in the third quarter predicting it will break the $2bn (€1.4bn) revenue mark this year.

Illumina's revenue soars as Affymetrix sues again

By  Dr Matt Wilkinson

Illumina's third quarter revenues soared 82 per cent while Affymetrix looked to bolster its slice of the genetics market by filing more patent infringement claims against the young pretender.